Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma.

Blood
Martina RudeliusMark Raffeld

Abstract

To determine whether the PI3K/Akt signaling pathway is involved in the pathogenesis of mantle cell lymphoma (MCL), we investigated the phosphorylation status of Akt and multiple downstream targets in primary MCL cases and cell lines. Akt was phosphorylated in 12 of 12 aggressive blastoid MCL variants and in 4 of 4 MCL cell lines. In contrast, phosphorylated Akt was present in only 5 of 16 typical MCL, 3 at comparable levels to the blastoid cases, and 2 at low levels. The presence of p-Akt was accompanied by the phosphorylation of p27(kip1), FRKHL-1, MDM2, Bad, mTOR, and p70S6K. Inhibition of the PI3K/Akt pathway in the MCL cell lines abrogated or reduced the phosphorylation of Akt, p27(kip1), FRKHL-1, MDM2, Bad, mTOR, GSK-3beta, IkappaB, and led to cell-cycle arrest and apoptosis. Six MCL cases (5 with activated Akt and 1 with inactive Akt) and 3 of 4 cell lines showed loss of PTEN expression. PIK3CA mutations were not detected. We conclude that constitutive activation of the PI3K/Akt pathway contributes to the pathogenesis of MCL and preferentially occurs in blastoid variants. One possible mechanism of activation is loss of PTEN expression. These data suggest that PI3K/Akt inhibitors may be effective in the treatment of Akt-ac...Continue Reading

References

Nov 15, 1996·Cell·T F Gajewski, C B Thompson
Jul 22, 1998·Oncogene·S PescheR Lidereau
Dec 16, 1998·Ryōikibetsu shōkōgun shirīzu·T Hayashi, Y Nonaka
Jan 23, 1999·Nature Genetics·L ShayestehJ W Gray
Mar 26, 1999·Genes, Chromosomes & Cancer·M P ButlerR Dalla-Favera
Mar 30, 1999·International Journal of Cancer. Journal International Du Cancer·X P ZhouR Hamelin
Aug 13, 1999·Genes & Development·A GrossS J Korsmeyer
Sep 15, 1999·Nature·J A Romashkova, S S Makarov
Jun 6, 2000·The Journal of Biological Chemistry·Y TanM J Comb
Aug 16, 2001·Proceedings of the National Academy of Sciences of the United States of America·L D Mayo, D B Donner
May 8, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Marie StahlRené H Medema
Jun 1, 2002·Science·Lewis C Cantley
Sep 24, 2002·Nature Medicine·Jiyong LiangJoyce M Slingerland
Oct 23, 2002·Molecular and Cellular Biology·Marc SchmidtRené H Medema
Feb 27, 2003·Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B·Sven de VosH Phillip Koeffler
Jun 21, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Lan V PhamRichard J Ford
Jul 10, 2003·Cell Cycle·Jiyong Liang, Joyce M Slingerland
Sep 26, 2003·Cancer Biology & Therapy·Monica M MitaEric K Rowinsky

❮ Previous
Next ❯

Citations

Sep 15, 2010·Annals of Hematology·Pinelopi ArgyriouDimitra Rontogianni
Oct 14, 2009·Molecular and Cellular Biochemistry·Sahdeo PrasadBharat B Aggarwal
Aug 8, 2009·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Qing WuYiquan Cheng
Apr 25, 2012·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Weicheng LiuJing Wang
Aug 21, 2007·Current Oncology Reports·Andre Goy
Jun 11, 2011·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Linzhu ZhaiTongyu Lin
Sep 26, 2013·Seminars in Cancer Biology·Carsten U Niemann, Adrian Wiestner
Feb 5, 2008·Expert Reviews in Molecular Medicine·Elias DrakosL Jeffrey Medeiros
Jun 4, 2013·Blood Cancer Journal·M Reis-SobreiroF Mollinedo
Nov 1, 2008·Nature Protocols·Brett SpurrierSatoshi Nishizuka
Mar 2, 2013·Nature Reviews. Drug Discovery·Ryan M Young, Louis M Staudt
Jul 26, 2013·Nature Reviews. Immunology·Robert C Rickert
Oct 20, 2010·The Journal of Experimental Medicine·Ana V MileticRobert C Rickert
Oct 1, 2013·Current Opinion in Oncology·Noridza Rivera-Rodriguez, Fernando Cabanillas
Aug 4, 2010·Current Opinion in Oncology·Catherine S M Diefenbach, Owen A O'Connor
Oct 2, 2012·The Journal of Clinical Investigation·Pedro JaresElias Campo
Feb 9, 2012·Haematologica·Christoph RennerUNKNOWN Swiss SAKK and French GOELAMS group from European Mantle Cell Lymphoma Network
Feb 27, 2009·Future Oncology·Elena M HartmannAndreas Rosenwald
Oct 11, 2013·Future Oncology·Adriana AritaJoshua D Brody
May 9, 2014·Current Opinion in Hematology·Maike Buchner, Markus Müschen
Aug 13, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Hongyan LvJinqiao Zhang
Jul 16, 2014·Current Hematologic Malignancy Reports·Tiffany Tang, Peter Martin
Dec 21, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J Y HongW S Kim
Apr 29, 2014·Pathology, Research and Practice·Wenlei LiuDongsheng Zhang
Sep 3, 2011·International Journal of Proteomics·Eun-Kyoung Yim Breuer, Mandi M Murph
Apr 3, 2008·Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B·Yu BaohuaShi Daren
Jun 28, 2011·Leukemia & Lymphoma·Amareshwar T K SinghLeo I Gordon
Jan 30, 2016·Drug Metabolism and Pharmacokinetics·Satoshi S Nishizuka, Gordon B Mills
Jan 24, 2013·Leukemia & Lymphoma·Simon HusbyKirsten Grønbæk

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.